Login / Signup

Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.

Kim Suzanne ThomasChristian J ApfelbacherJoanne R ChalmersE SimpsonP I SpulsLouise A A GerbensH C WilliamsJochen SchmittM GabesL HowellsBeth L StuartErin E GrinichT PawlitschekT BurtonL HowieA GadkariLaurent EckertT EbataM BoersH SaekiT NakaharaNorito Katoh
Published in: The British journal of dermatology (2020)
For now, the core outcome set for clinical trials in atopic eczema is complete. The specified domains and instruments should be used in all new clinical trials and systematic reviews of eczema treatments.
Keyphrases
  • atopic dermatitis
  • clinical trial
  • systematic review
  • healthcare
  • patient reported outcomes
  • phase ii
  • open label
  • high intensity
  • phase iii
  • clinical practice
  • randomized controlled trial
  • study protocol
  • meta analyses